99 related articles for article (PubMed ID: 89652)
41. [Current considerations on the behavior of serum alpha-fetoprotein as a tumor marker].
Ruibal A; Guarga A; Encabo G; Urrutia A
Med Clin (Barc); 1985 Nov; 85(16):687-8. PubMed ID: 2417068
[No Abstract] [Full Text] [Related]
42. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
43. [A long term follow-up study in patients with chronic liver diseases with special reference to serum alpha-fetoprotein].
Ohtsuyama Y
Nihon Shokakibyo Gakkai Zasshi; 1982 Oct; 79(10):1962-9. PubMed ID: 6185707
[No Abstract] [Full Text] [Related]
44. Several conditions causing elevation of serum alpha-fetoprotein: experience at King Faisal Specialist Hospital and Research Centre.
Tsung JS
Indiana Med; 1988 Jan; 81(1):32-4. PubMed ID: 2449490
[No Abstract] [Full Text] [Related]
45. [Radioimmunoassay determination of alpha fetoprotein. Rapid method].
Kanao K; Ishihara S; Honda M; Ogawa T; Yagi E
Radioisotopes; 1978 Jan; 27(1):46-9. PubMed ID: 76324
[No Abstract] [Full Text] [Related]
46. Elevated alpha-fetoprotein in association with loss of serum HBeAg.
McDonnell WM; Lucey MR
Am J Gastroenterol; 1993 Sep; 88(9):1441-3. PubMed ID: 7689785
[No Abstract] [Full Text] [Related]
47. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
[TBL] [Abstract][Full Text] [Related]
48. [Carcinoembryonic antigen and alpha fetoprotein in kidney diseases].
Kowalski D; Starzyk J; Słuszniak A
Wiad Lek; 1987 May; 40(10):660-4. PubMed ID: 2445113
[No Abstract] [Full Text] [Related]
49. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
[TBL] [Abstract][Full Text] [Related]
50. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
51. [Clinical significance of alpha-fetoprotein and carcinoembryonic antigen in the serum of patients with liver cirrhosis].
Libman E; Feher I; Lemberger J; Mutibarić A
Med Pregl; 1979; 32(5-6):229-32. PubMed ID: 90328
[No Abstract] [Full Text] [Related]
52. Alphafetoprotein in liver disease.
Ahmed W; Lodi TZ; Zuberi SJ
J Pak Med Assoc; 1988 Sep; 38(9):234-6. PubMed ID: 2467997
[No Abstract] [Full Text] [Related]
53. Value of serum protective activity against acid precipitation of poly (U) in the differentiation between cirrhotic patients with and without hepatocellular carcinoma.
Kouretas D; Kountouras J; Tsapas G; Anastasiades N; Tsakiri I; Antonoglou O
Anticancer Res; 1990; 10(4):1025-8. PubMed ID: 1696444
[TBL] [Abstract][Full Text] [Related]
54. [Follow-up analysis of persistent low positive serum alpha-fetoprotein (AFP)--report on 420 cases].
Zhang BC
Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):26-8. PubMed ID: 2579782
[No Abstract] [Full Text] [Related]
55. [Alpha feto protein].
Vaur JL
Infirm Fr; 1982 Feb; (232):27-8. PubMed ID: 6174446
[No Abstract] [Full Text] [Related]
56. Stromal-predominant mesenchymal hamartoma of the liver with elevated serum alpha-fetoprotein level.
Gunes D; Uysal KM; Cecen E; Cakmakci H; Ozer E; Akgur FM; Olgun N
Pediatr Hematol Oncol; 2008 Sep; 25(7):685-92. PubMed ID: 18850482
[TBL] [Abstract][Full Text] [Related]
57. [A retrospective study of the serum CEA, AFP, TPA and ferritin values in 500 patients with chronic liver diseases].
Cioffi M; Fratta M; De Lucia D; Bresciani F
Arch Monaldi Mal Torace; 1990; 45(3):159-65. PubMed ID: 1726999
[TBL] [Abstract][Full Text] [Related]
58. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
Stránský J; Zichová M; Vodák M
Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
[TBL] [Abstract][Full Text] [Related]
59. [Eicosanoids in chronic liver diseases].
Malaia LT; Grishina EI; Babak OIa; Iabluchanskií NI
Klin Med (Mosk); 1991 Mar; 69(3):48-51. PubMed ID: 2067335
[TBL] [Abstract][Full Text] [Related]
60. [Measurement of alpha-fetoprotein by radioimmunometric assay using plastic bead as a solid phase (author's transl)].
Iio A; Wada M; Ata M; Ito H; Koizumi M; Ishine M; Inatsuki S; Hamamoto K
Kaku Igaku; 1982 Mar; 19(2):323-9. PubMed ID: 6180195
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
